We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.89B
AUM Growth
+$159M
Cap. Flow
+$27.9M
Cap. Flow %
1.48%
Top 10 Hldgs %
34.09%
Holding
355
New
45
Increased
117
Reduced
138
Closed
28

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$36.2M
2
WST icon
West Pharmaceutical
WST
+$24.3M
3
NVST icon
Envista
NVST
+$23.9M
4
JPM icon
JPMorgan Chase
JPM
+$22.1M
5
ETN icon
Eaton
ETN
+$15.3M

Sector Composition

Rank Sector Weight
1 Technology 30.41%
2 Consumer Discretionary 14.8%
3 Healthcare 14.63%
4 Financials 11.82%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
351
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-282,047
Closed -$20.7M
BDSI
352
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-63,049
Closed -$265K
CEO
353
DELISTED
CNOOC Limited
CEO
-277
Closed -$25K

Similar funds

Smith Group Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Smith Group Asset Management held 355 positions worth $1.89B, up 9.2% from $1.73B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Smith Group Asset Management's Q1 2021 filing shows 45 new, 117 increased, 138 reduced and 28 closed positions. Its largest new stake was West Pharmaceutical: 84,965 shares worth $24M. The largest sale was Apple, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Smith Group Asset Management's largest Q1 2021 buy was West Pharmaceutical: 84,965 shares worth $24M.
  • Smith Group Asset Management added most to Capital One in Q1 2021, an estimated $36.2M increase.
  • Smith Group Asset Management's biggest Q1 2021 reduction was Apple, cutting an estimated $23.5M.
  • Smith Group Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021, selling an estimated $20.7M.
  • Smith Group Asset Management's ten largest holdings make up 34% of its $1.89B portfolio in Q1 2021.
  • Smith Group Asset Management opened 45 new positions and closed 28 in Q1 2021.
  • Smith Group Asset Management's portfolio value rose 9.2% quarter-over-quarter to $1.89B.

Based on Smith Group Asset Management's 13F filing for Q1 2021, filed 7 May 2021.